and PIRS is exciting news and shows how PIRS is moving forward in the oncology space; PD-1 antibodies binding to anticalins is another piece of the puzzle for PIRS to develop one aspect of their compound. These guys are serious and have a plan to develop many drugs for monetization!
Major b👻Tchfest for a genius but no resolution major dislikes for the candidates but no conclusion hope you feel better after the fest
hippa laws are pertinent to personal info...nothing personal shared here.
Mine as well, thanks for sharing that info MGM. Networking w/ patients is at times rewarding , 15/day is a very good location if consistent. Regards
Thank you Tursta for this exciting info., seems as though some investors on this board are becoming less enthused with their investment based on price action, I like to defer to PCYC in early stages.
yes I think pirs is a very intriguing company, 3companys investing cash for 3 potential products, but like all bios the trial results are numero uno.
Played icpt 2 times and missed the great buy at 95, had a"great buy at 211 about 1 1/2 yr ago then it went to 165, patients payed off , back up to 300+. Which is why my annoyance of missing 95.
thanks biotrader for the link , just now watched it .....very impressively laid out and a very organized game plan!! I am as much enthused now as ranger!